Search research articles
Contact Us
Filters
Showing results (31-40 of 147) with videos related to
Page
of 15
Sort By:
Oncotarget
|
March 16, 2018
Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients
Sagus Sampath, Haejung Won, Erminia Massarelli, et al.
EMBO Reports
|
August 16, 2008
Chondroitin sulphate-modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas-mediated pathway
Paul Frankel, Caroline Pellet-Many, Pauliina Lehtolainen, et al.
Leukemia & Lymphoma
|
December 27, 2013
A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study
Mark H Kirschbaum, Kenneth A Foon, Paul Frankel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2015
Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors
Sumanta K Pal, Sierra M Li, Xiwei Wu, et al.
Investigational New Drugs
|
October 12, 2010
Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study
Robert J Morgan, Lucille Leong, Warren Chow, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 20, 2008
Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma
Suresh S Ramalingam, Chandra P Belani, Christopher Ruel, et al.
Development (Cambridge, England)
|
June 7, 2019
Neuropilin 1 mediates epicardial activation and revascularization in the regenerating zebrafish heart
Vanessa Lowe, Laura Wisniewski, Jacob Sayers, et al.
Cardiovascular Research
|
July 16, 2021
Bcar1/p130Cas is essential for ventricular development and neural crest cell remodelling of the cardiac outflow tract
Marwa Mahmoud, Ian Evans, Laura Wisniewski, et al.
Cancer
|
September 12, 2019
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma
Warren Chow, Paul Frankel, Chris Ruel, et al.
Breast Cancer Research and Treatment
|
April 19, 2011
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology
George Somlo, Sean K Lau, Paul Frankel, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 147) with videos related to
Sort By:
Page
of 15
Oncotarget
|
March 16, 2018
Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients
Sagus Sampath, Haejung Won, Erminia Massarelli, et al.
EMBO Reports
|
August 16, 2008
Chondroitin sulphate-modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas-mediated pathway
Paul Frankel, Caroline Pellet-Many, Pauliina Lehtolainen, et al.
Leukemia & Lymphoma
|
December 27, 2013
A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study
Mark H Kirschbaum, Kenneth A Foon, Paul Frankel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2015
Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors
Sumanta K Pal, Sierra M Li, Xiwei Wu, et al.
Investigational New Drugs
|
October 12, 2010
Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study
Robert J Morgan, Lucille Leong, Warren Chow, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 20, 2008
Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma
Suresh S Ramalingam, Chandra P Belani, Christopher Ruel, et al.
Development (Cambridge, England)
|
June 7, 2019
Neuropilin 1 mediates epicardial activation and revascularization in the regenerating zebrafish heart
Vanessa Lowe, Laura Wisniewski, Jacob Sayers, et al.
Cardiovascular Research
|
July 16, 2021
Bcar1/p130Cas is essential for ventricular development and neural crest cell remodelling of the cardiac outflow tract
Marwa Mahmoud, Ian Evans, Laura Wisniewski, et al.
Cancer
|
September 12, 2019
Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma
Warren Chow, Paul Frankel, Chris Ruel, et al.
Breast Cancer Research and Treatment
|
April 19, 2011
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology
George Somlo, Sean K Lau, Paul Frankel, et al.
Page
of 15